Literature DB >> 15731495

Association of C-reactive protein with blood pressure and hypertension: life course confounding and mendelian randomization tests of causality.

George Davey Smith1, Debbie A Lawlor, Roger Harbord, Nic Timpson, Ann Rumley, Gordon D O Lowe, Ian N M Day, Shah Ebrahim.   

Abstract

BACKGROUND: C-reactive protein (CRP) has repeatedly been associated with blood pressure and prevalent and incident hypertension, but whether a causal link exists is uncertain. METHODS AND
RESULTS: We assessed the cross-sectional relations of CRP to systolic blood pressure, pulse pressure, and prevalent hypertension in a representative sample of >3500 British women aged 60 to 79 years. For both outcomes, substantial associations were observed. However, these associations were greatly attenuated by adjustment for a wide range of confounding factors acting over the life course. We further investigated causality using a Mendelian randomization approach by examining the association of the 1059G/C polymorphism in the human CRP gene with CRP and with blood pressure, pulse pressure, and hypertension. The polymorphism was associated with a robust difference in CRP, and the expectation would be for higher blood pressure and pulse pressure and greater prevalence of hypertension among those carrying the genetic variant associated with higher CRP levels. This was not observed, and the predicted causal effects of CRP on blood pressure, pulse pressure, and hypertension using instrumental variables methods were close to 0, although with wide CIs.
CONCLUSIONS: CRP levels are associated with blood pressure, pulse pressure, and hypertension, but adjustment for life course confounding and a Mendelian randomization approach suggest the elevated CRP levels do not lead to elevated blood pressure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15731495     DOI: 10.1161/01.ATV.0000160351.95181.d0

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  66 in total

1.  Neighborhoods and systemic inflammation: high CRP among legal and unauthorized Brazilian migrants.

Authors:  Louisa M Holmes; Enrico A Marcelli
Journal:  Health Place       Date:  2012-01-16       Impact factor: 4.078

2.  Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease.

Authors:  Caroline L Relton; George Davey Smith
Journal:  Int J Epidemiol       Date:  2012-02       Impact factor: 7.196

3.  Randomised by (your) god: robust inference from an observational study design.

Authors:  George Davey Smith
Journal:  J Epidemiol Community Health       Date:  2006-05       Impact factor: 3.710

Review 4.  Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology?

Authors:  Shah Ebrahim; George Davey Smith
Journal:  Hum Genet       Date:  2007-11-23       Impact factor: 4.132

Review 5.  Impact of genetic and environmental factors on hsCRP concentrations and response to therapeutic agents.

Authors:  Jian Shen; Jose M Ordovas
Journal:  Clin Chem       Date:  2008-12-12       Impact factor: 8.327

6.  C-reactive protein genotypes and haplotypes, polymorphisms in NSAID-metabolizing enzymes, and risk of colorectal polyps.

Authors:  Elizabeth M Poole; Jeannette Bigler; John Whitton; Justin G Sibert; John D Potter; Cornelia M Ulrich
Journal:  Pharmacogenet Genomics       Date:  2009-02       Impact factor: 2.089

Review 7.  Role of the Immune System in Hypertension.

Authors:  Bernardo Rodriguez-Iturbe; Hector Pons; Richard J Johnson
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

8.  C-reactive protein and substance use disorders in adolescence and early adulthood: a prospective analysis.

Authors:  E Jane Costello; William E Copeland; Lilly Shanahan; Carol M Worthman; Adrian Angold
Journal:  Drug Alcohol Depend       Date:  2013-09-10       Impact factor: 4.492

9.  Unraveling the directional link between adiposity and inflammation: a bidirectional Mendelian randomization approach.

Authors:  Paul Welsh; Eliana Polisecki; Michele Robertson; Sabine Jahn; Brendan M Buckley; Anton J M de Craen; Ian Ford; J Wouter Jukema; Peter W Macfarlane; Chris J Packard; David J Stott; Rudi G J Westendorp; James Shepherd; Aroon D Hingorani; George Davey Smith; Ernst Schaefer; Naveed Sattar
Journal:  J Clin Endocrinol Metab       Date:  2009-11-11       Impact factor: 5.958

10.  Metabolic Syndrome, Physical Activity, and Inflammation: A Cross-Sectional Analysis of 110 Circulating Biomarkers in Japanese Adults.

Authors:  Sarah C Van Alsten; Charles S Rabkin; Norie Sawada; Taichi Shimazu; Hadrien Charvat; Taiki Yamaji; Manami Inoue; Troy J Kemp; Ligia A Pinto; M Constanza Camargo; Shoichiro Tsugane; Minkyo Song
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-28       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.